CoChat

MODY Probability Calculator Is Suitable for MODY Screening in China: A Population-based Study

Zhao, Jing, Chen, Yan, Ma, Fuhui, Shu, Hua, Zheng, Li, Liu, Yang, Li, Xia, Xu, Tao, Zhou, Zhiguang, Zhou, Kaixin · 2024 · Journal of the Endocrine Society
Cited by 8

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Context: Selecting appropriate individuals for genetic testing is essential due to the optimal treatment for maturity-onset diabetes of the young (MODY). However, how to effectively screen for MODY in China remains unclear. Objective: To validate the performance of current screening strategies in selecting patients with MODY based on a nationwide type 2 diabetes cohort. Methods: A panel of 14 MODY genes was analyzed from 1911 type 2 diabetes patients who were ages 15 to 35 years. Variants were evaluated according to the American College of Medical Genetics and Genomics guidelines. Based on this cohort, we simulated the 2 most frequently used screening strategies, including the traditional MODY criteria and the MODY probability calculator (MPC), to assess their ability to select patients with MODY. Results: From a total of 1911 participants, 42 participants harbored pathogenic/likely pathogenic variants. The performance of the traditional criteria was sensitivity: 19.0%, specificity: 72.9%, positive predictive value (PPV): 1.6%, and missing rate: 81.0%. The optimal cut-off for MPC was 40.7%. Based on this cut-off value, the performance was sensitivity: 54.8%, specificity: 81.0%, PPV: 6.1%, and missing rate: 45.2%. Moreover, hemoglobin A1c, insulin treatment, and family history of diabetes have poor discrimination between MODY and young-onset type 2 diabetes. Conclusion: The MPC is better than traditional criteria in terms of both sensitivity and PPV. To ensure more MODY patients benefit from optimal treatment, we therefore suggest that routine genetic testing be performed on all type 2 diabetes patients who are between the ages of 15 and35 years and have MPC probability value over 40.7%.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jendso/bvae047

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 35

  1. Flannick, 2016, Common and rare forms of diabetes mellitus: towards a continuum of diabetes subtypes, Nat Rev Endocrinol, 12, 394, 10.1038/nrendo.2016.50 · DOI
  2. Shepherd, 2003, No deterioration in glycemic control in HNF-1alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas, Diabetes Care, 26, 3191, 10.2337/diacare.26.11.3191-a · DOI · Paper page
  3. Steele, 2014, Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia, Jama, 311, 279, 10.1001/jama.2013.283980 · DOI · Paper page
  4. Zhang, 2021, Monogenic diabetes: a gateway to precision medicine in diabetes, J Clin Invest, 131, e142244, 10.1172/JCI142244 · DOI · Paper page
  5. Thanabalasingham, 2012, Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young, Diabetes Care, 35, 1206, 10.2337/dc11-1243 · DOI · Paper page
  6. Thanabalasingham, 2011, Diagnosis and management of maturity onset diabetes of the young (MODY), Bmj, 343, d6044, 10.1136/bmj.d6044 · DOI · Paper page
  7. Misra, 2018, Genetics of monogenic diabetes: present clinical challenges, Curr Diab Rep, 18, 141, 10.1007/s11892-018-1111-4 · DOI
  8. Kleinberger, 2018, Monogenic diabetes in overweight and obese youth diagnosed with type 2 diabetes: the TODAY clinical trial, Genet Med, 20, 583, 10.1038/gim.2017.150 · DOI · Paper page
  9. Stanik, 2014, De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed, Diabetologia, 57, 480, 10.1007/s00125-013-3119-2 · DOI
  10. Yang, 2014, Early therapy for type 2 diabetes in China, Lancet Diabetes Endocrinol, 2, 992, 10.1016/S2213-8587(14)70136-6 · DOI
  11. Shields, 2012, The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes, Diabetologia, 55, 1265, 10.1007/s00125-011-2418-8 · DOI · Paper page
  12. Pang, 2022, Improvements in awareness and testing have led to a threefold increase over 10 years in the identification of monogenic diabetes in the U.K, Diabetes Care, 45, 642, 10.2337/dc21-2056 · DOI
  13. Harrington, 2023, Monogenic diabetes in New Zealand—an audit based revision of the monogenic diabetes genetic testing pathway in New Zealand, Front Endocrinol (Lausanne), 14, 1116880, 10.3389/fendo.2023.1116880 · DOI
  14. da Silva Santos, 2022, MODY probability calculator utility in individuals’ selection for genetic testing: its accuracy and performance, Endocrinol Diabetes Metab, 5, e00332, 10.1002/edm2.332 · DOI
  15. Hohendorff, 2019, The utility of MODY Probability Calculator in probands of families with early-onset autosomal dominant diabetes from Poland, Minerva Med, 110, 499
  16. Ang, 2016, A preliminary study to evaluate the strategy of combining clinical criteria and next generation sequencing (NGS) for the identification of monogenic diabetes among multi-ethnic Asians, Diabetes Res Clin Pract, 119, 13, 10.1016/j.diabres.2016.06.008 · DOI
  17. Santomauro, 2023, The performance of the MODY calculator in a non-Caucasian, mixed-race population diagnosed with diabetes mellitus before 35 years of age, Diabetol Metab Syndr, 15, 15, 10.1186/s13098-023-00985-3 · DOI
  18. Wang, 2017, Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013, Jama, 317, 2515, 10.1001/jama.2017.7596 · DOI · Paper page
  19. Donath, 2019, Next-generation sequencing identifies monogenic diabetes in 16% of patients with late adolescence/adult-onset diabetes selected on a clinical basis: a cross-sectional analysis, BMC Med, 17, 132, 10.1186/s12916-019-1363-0 · DOI
  20. Ellard, 2013, Improved genetic testing for monogenic diabetes using targeted next-generation sequencing, Diabetologia, 56, 1958, 10.1007/s00125-013-2962-5 · DOI · Paper page
  21. Szopa, 2015, Genetic testing for monogenic diabetes using targeted next-generation sequencing in patients with maturity-onset diabetes of the young, Pol Arch Med Wewn, 125, 845, 10.20452/pamw.3164 · DOI
  22. Kleinberger, 2015, Time for action, Curr Diab Rep, 15, 110, 10.1007/s11892-015-0681-7 · DOI
  23. Hattersley, 2017, Precision diabetes: learning from monogenic diabetes, Diabetologia, 60, 769, 10.1007/s00125-017-4226-2 · DOI · Paper page
  24. Chen, 2023, Prevalence of maturity-onset diabetes of the young in phenotypic type 2 diabetes in young adults: a nationwide, multi-center, cross-sectional survey in China, Chin Med J (Engl), 136, 56, 10.1097/CM9.0000000000002321 · DOI
  25. Li, 2019, Prevalence of metabolic syndrome and its determinants in newly-diagnosed adult-onset diabetes in China: a multi-center, cross-sectional survey, Front Endocrinol (Lausanne), 10, 661, 10.3389/fendo.2019.00661 · DOI · Paper page
  26. Ma, 2014, Causes of type 2 diabetes in China, Lancet Diabetes Endocrinol, 2, 980, 10.1016/S2213-8587(14)70145-7 · DOI
  27. Aarthy, 2021, Clinical features, complications and treatment of rarer forms of maturity-onset diabetes of the young (MODY)—a review, J Diabetes Complications, 35, 107640, 10.1016/j.jdiacomp.2020.107640 · DOI
  28. Schwarz, 2014, MutationTaster2: mutation prediction for the deep-sequencing age, Nat Methods, 11, 361, 10.1038/nmeth.2890 · DOI · Paper page
  29. Ng, 2003, SIFT: Predicting amino acid changes that affect protein function, Nucleic Acids Res, 31, 3812, 10.1093/nar/gkg509 · DOI · Paper page
  30. Rentzsch, 2019, CADD: predicting the deleteriousness of variants throughout the human genome, Nucleic Acids Res, 47, D886, 10.1093/nar/gky1016 · DOI · Paper page
  31. Adzhubei, 2013, Predicting functional effect of human missense mutations using PolyPhen-2, Curr Protoc Hum Genet, Chapter 7, Unit7.20
  32. Shihab, 2013, Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models, Hum Mutat, 34, 57, 10.1002/humu.22225 · DOI · Paper page
  33. Robin, 2011, pROC: an open-source package for R and S+ to analyze and compare ROC curves, BMC Bioinformatics, 12, 77, 10.1186/1471-2105-12-77 · DOI · Paper page
  34. Timsit, 2021, Pregnancy in women with monogenic diabetes due to pathogenic variants of the glucokinase gene: lessons and challenges, Front Endocrinol (Lausanne), 12, 802423, 10.3389/fendo.2021.802423 · DOI
  35. Park, 2019, Identifying pathogenic variants of monogenic diabetes using targeted panel sequencing in an east Asian population, J Clin Endocrinol Metab, 104, 4188, 10.1210/jc.2018-02397 · DOI

Cited by

See all 8

Metadata

Authors
Zhao, J., Chen, Y., Ma, F., Shu, H., Zheng, L., Liu, Y., Li, X., Xu, T., Zhou, Z., & Zhou, K.
Affiliations
  • College of Life Sciences, University of Chinese Academy of Sciences , Beijing 101408 , China
  • National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University , Changsha, Hunan 410011 , China
  • Department of Endocrinology and Metabolic Diseases, People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Research Center for Diabetes , Urumqi, 830001 , China
  • Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital , Heping District, Tianjin, 300052 , China
  • Key Laboratory of RNA Biology, Center for Big Data Research in Health, Institute of Biophysics, Chinese Academy of Sciences , Beijing 100101 , China
  • Guangzhou Laboratory , Guangdong Province, Guangdong 510005 , China
Venue
Journal of the Endocrine Society
Published
2024-03-12
Volume
8
Issue
5
ISSN
2472-1972
Cited by
8
References
4
Language
en
Funders
Natural Science Foundation of Xinjiang Uygur Autonomous Region of China (2022D01C618)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MODY Probability Calculator Is Suitable for MODY Screening in China: A Population-based Study. https://app.cochat.ai/papers/10.1210/jendso/bvae047
The paper
Zhao, J., Chen, Y., Ma, F., Shu, H., Zheng, L., Liu, Y., Li, X., Xu, T., Zhou, Z., & Zhou, K. (2024). MODY Probability Calculator Is Suitable for MODY Screening in China: A Population-based Study. Journal of the Endocrine Society. https://doi.org/10.1210/jendso/bvae047

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.